Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity

References

• Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002;122: 531–44.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806–15.
   PubMed Web of Science ®Google Scholar
• Ménétrier P. Des polyadenomes gastriques et de leurs repports avec le cancer de l’estomac. Arch Physiol Norm Path 1–1888;32:236–62.
   Google Scholar
• Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Ménétrier Study Group. Scand J Gastroenterol 1992;194: 1–7.
   Google Scholar
• Bayerdorffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori: is Helicobacter pylori a pathogenic factor in Ménétrier’s disease? Gut 1994;35: 701–4.
   Google Scholar
• Kawasaki M, Hizawa K, Aoyagi K, Nakamura S, Fujishima M. Ménétrier’s disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypopro- teinemia after antibacterial treatment. Am J Gastroenterol 1997;92: 1909–12.
   Google Scholar
• Kovacs AA, Churchill MA, Wood D, Mascola L, Zaia JA. Molecular and epidemiologic evaluations of a cluster of cases of Ménétrier’s disease associated with cytomegalovirus. Pediatr Infect Dis J 1993;12:1011–4.
   Google Scholar
• Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930–2.
   Google Scholar
• Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989;1:1167–8.
   PubMed Web of Science ®Google Scholar
• Doran AC, Wan YP, Kopin AS, Beinborn M. Established theory of radiation-induced decay is not generalizable to Bolton-Hunter labeled peptides. Biochem Pharmacol 2003; 65:1515–20.
   PubMedGoogle Scholar
• Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Miyazaki Y, et al. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39:787–94.
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575–82.
   PubMed Web of Science ®Google Scholar
• Lehmann FS, Golodner EH, Wang J, Chen MC, Avedian D, Calam J, et al. Mononuclear cells and cytokines stimulate gastrin release from canine antral cells in primary culture. Am J Physiol 1996;270:G783–8.
   PubMed Web of Science ®Google Scholar
• Kramling HJ, Enders G, Teichmann RK, Demmel T, Merkle R, Brendel W. Antigen-induced gastrin release: an immunologic mechanism of gastric antral mucosa. Adv Exp Med Biol 1987;216A:427–9.
   PubMedGoogle Scholar
• Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473–7.
   PubMed Web of Science ®Google Scholar
• Ishihara S, Fukuda R, Moriyama N, Ishimura N, Kaji T, Kushiyama Y, et al. Helicobacter pylori infection accelerates gene expression of glicentin in the gastric mucosa. Its association with intestinal metaplasia of the stomach. Scand J Gastroenterol 1997;32:460–4.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Hartmann B, Hansen BS, Thulesen J, Holst JJ, Mortensen PB. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999;45:559–63.
   PubMed Web of Science ®Google Scholar
• Guan X, Stoll B, Lu X, Tappenden KA, Holst JJ, Hartmann B, et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN- fed piglets. Gastroenterology 2003;125:136–47.
   PubMed Web of Science ®Google Scholar
• Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 1999;96:1569–73.
   PubMed Web of Science ®Google Scholar
• Wojdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab 1999;84: 2513–7.
   Google Scholar
• Wojdemann M, Wettergren A, Hartmann B, Holst JJ. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 1998;33:828–32.
   PubMed Web of Science ®Google Scholar
• Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 2001; 119:744–55.
   Google Scholar
• Bjerknes M, Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 2001;98:12497–502.
   PubMed Web of Science ®Google Scholar
• Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, et al. Treatment of Ménétrier’s disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med 2000;343:1697–701.
   PubMedGoogle Scholar
• Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology 1992;103:1950–63.
   PubMed Web of Science ®Google Scholar